Trial reportBrain, behavior, and immunity2026
Insomnia and inflammatory exposure impair spatial memory and cognitive mapping in older adults: a randomized controlled trial.
Trial report in Brain, behavior, and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundInsomnia and inflammation are both risk factors for cognitive aging, especially declines of spatial memory and cognitive mapping. This study aimed to evaluate whether older adults with insomnia show deficits in spatial memory and cognitive mapping, and whether an inflammatory challenge might exacerbate those deficits.
methodsWe analyzed secondary outcomes of an assessor-blinded, parallel-condition, placebo-controlled randomized clinical trial in 84 non-depressed adults aged 60-80 years (26 with insomnia disorder, 58 without insomnia) who were randomized to low-dose intravenous endotoxin or placebo. Two hours post-injection, participants completed a virtual Morris water maze task assessing spatial memory, followed by a room reconstruction task assessing cognitive mapping under real-world conditions. Circulating levels of inflammatory cytokines were repeatedly measured.
resultsAmong 84 randomized participants (66.0 ± 4.6 years; 50.0% female), 39 participants (12 insomnia; 27 control) received endotoxin and 45 (14 insomnia; 31 control) placebo. Older adults with insomnia showed impairments in spatial memory and cognitive mapping as compared to controls (P's < 0.01). Further, a significant group (insomnia vs. control) × condition (endotoxin vs. placebo) interaction emerged (P < 0.05), with post hoc tests revealing deficits in cognitive mapping in older adults with insomnia exposed to endotoxin (P < 0.01), but not in insomnia patients who received placebo or in controls. Cytokine responses were not related to spatial memory or mapping outcomes.
conclusionOlder adults with insomnia, as compared to controls, exhibit deficits in spatial memory and cognitive mapping, and the latter appears to be exaggerated following inflammatory exposure. Both insomnia and inflammation are potential mechanistic targets to preserve cognitive aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.